Dr. Dietrich shares his research which explores structural and functional brain repair mechanisms after cancer therapy induced nervous system injury.
Are the neuroprotective effects mediated by G-CSF-responsive brain cells or circulating (marrow-derived) cells?
Dr. Dietrich reports the following consulting fees or paid advisory boards for the past two years: Monteris Medical Corporation, Unum Therapeutics, and Blue Earth Diagnostics.
Dr. Dietrich reports the following current grant support, including non-profit/government entitites: Amy Gallagher Foundation 2017-2019, NIH R21 2018-2020, NIH R01 2018-2022.